NO924585L - Peptider med insulinaktig virkning - Google Patents

Peptider med insulinaktig virkning

Info

Publication number
NO924585L
NO924585L NO92924585A NO924585A NO924585L NO 924585 L NO924585 L NO 924585L NO 92924585 A NO92924585 A NO 92924585A NO 924585 A NO924585 A NO 924585A NO 924585 L NO924585 L NO 924585L
Authority
NO
Norway
Prior art keywords
residue
acid residue
alkyl
hydrogen atom
radical
Prior art date
Application number
NO92924585A
Other languages
English (en)
Other versions
NO924585D0 (no
NO309146B1 (no
Inventor
Wendelin Frick
Guenter Mueller
Stefan Muellner
Gerhard Breipohl
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO924585D0 publication Critical patent/NO924585D0/no
Publication of NO924585L publication Critical patent/NO924585L/no
Publication of NO309146B1 publication Critical patent/NO309146B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO924585A 1991-11-29 1992-11-27 Peptider med insulinaktig virkning NO309146B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4139376 1991-11-29

Publications (3)

Publication Number Publication Date
NO924585D0 NO924585D0 (no) 1992-11-27
NO924585L true NO924585L (no) 1993-06-01
NO309146B1 NO309146B1 (no) 2000-12-18

Family

ID=6445910

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924585A NO309146B1 (no) 1991-11-29 1992-11-27 Peptider med insulinaktig virkning

Country Status (11)

Country Link
US (1) US5622934A (no)
EP (1) EP0545198B1 (no)
JP (1) JP3324804B2 (no)
AT (1) ATE184611T1 (no)
DE (1) DE59209745D1 (no)
DK (1) DK0545198T3 (no)
ES (1) ES2137937T3 (no)
FI (1) FI925370A (no)
GR (1) GR3031850T3 (no)
NO (1) NO309146B1 (no)
SG (1) SG46640A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19512484A1 (de) 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
US5948751A (en) * 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
KR100481746B1 (ko) * 1996-11-28 2005-08-10 훽스트 악티엔게젤샤프트 인슐린-유사작용을갖는이노시톨글리칸및이를포함하는약제학적제제
DE19649350A1 (de) * 1996-11-28 1998-06-04 Hoechst Ag Inositolglykane mit insulinartiger Wirkung
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
DK2089417T3 (en) * 2006-10-12 2015-03-23 Bhi Ltd Partnership Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801175A1 (de) * 1978-01-12 1979-07-19 Hoechst Ag Verfahren zur herstellung cysteinhaltiger peptide
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
US4515920A (en) * 1984-04-30 1985-05-07 The Rockefeller University Synthesis of peptides and proteins
AU605214B2 (en) * 1986-10-24 1991-01-10 Fresenius Kabi Ab N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
EP0288897B1 (de) * 1987-04-25 1993-08-11 Hoechst Aktiengesellschaft Enkastine: Neue Glycopeptide mit Enkephalinase-hemmender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als pharmazeutische Präparate
NZ232562A (en) * 1989-02-17 1992-10-28 Coselco Mimotopes Pty Ltd Immobilised peptide - solid support comprising a cleavable ester link between the peptide carboxy terminus and the solid support
AU6733190A (en) * 1989-11-27 1991-06-26 Santen Pharmaceutical Co. Ltd. Amino acid derivative
TW227004B (no) * 1990-12-19 1994-07-21 Hoechst Ag
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin

Also Published As

Publication number Publication date
JPH05247088A (ja) 1993-09-24
DE59209745D1 (de) 1999-10-21
FI925370A0 (fi) 1992-11-26
DK0545198T3 (da) 2000-03-20
FI925370A (fi) 1993-05-30
EP0545198A2 (de) 1993-06-09
GR3031850T3 (en) 2000-02-29
NO924585D0 (no) 1992-11-27
EP0545198B1 (de) 1999-09-15
ES2137937T3 (es) 2000-01-01
EP0545198A3 (no) 1994-03-23
JP3324804B2 (ja) 2002-09-17
US5622934A (en) 1997-04-22
SG46640A1 (en) 1998-02-20
NO309146B1 (no) 2000-12-18
ATE184611T1 (de) 1999-10-15

Similar Documents

Publication Publication Date Title
DE69210640D1 (de) Zahnmedizinische/medizinische Zusammensetzung für Restaurations-/Prothesenzwecke und ihre Verwendung
ATE196298T1 (de) Oberflächenaktives lungenprotein und verwandte polypeptide
AU564648B2 (en) Insulin agent
ES2190469T3 (es) Derivados de isocumarina y su uso en farmacos.
DE59400751D1 (de) Glycosidreste aufweisende Organosiliciumverbindungen und Verfahren zu deren Herstellung
DE69110101D1 (de) GIP-Analoge und deren Verwendung.
SE8102194L (sv) Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
ATE185564T1 (de) Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
ES2071815T3 (es) Analogos de delecion de los peptidos conocidos como magaininas.
NO924585D0 (no) Peptider med insulinaktig virkning
FI935318A (fi) 15-deoksispergualiinianalogit, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
ATE92469T1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
ATE68177T1 (de) Alpha-hydroxythioether.
KR890012929A (ko) 2개의 방향족 환 함유 화합물의 디아실화 방법
HU896173D0 (no)
EP0328913A3 (de) Neue basisch substituierte 5-Halogen-Thienoisothiazol-3(2H)-on-1,1-dioxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
ZA89431B (en) Oxadiazole compounds,their preparation and their use as pesticides
ATE102953T1 (de) Retro-inverso-thrymopentin-analoge, verfahren zu deren herstellung und deren verwendung fuer die zubereitung von pharmazeutischen zusammensetzungen.
ATE87939T1 (de) Glycosylierte aminosaeuren und peptide.
DE69017771D1 (de) Thymopentin-Analoge mit allen umgekehrten Verbindungen, Verfahren zur deren Herstellung und deren Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen.
ATE80161T1 (de) Ketendithioacetal-derivate und verfahren zu deren herstellung und diese enthaltende zusammenstellung.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003